These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25534790)

  • 1. Introduction of a routine quan/qual approach into research DMPK: experiences and evolving strategies.
    King L; Kotian A; Jairaj M
    Bioanalysis; 2014; 6(24):3337-48. PubMed ID: 25534790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometric recommendations for Quan/Qual analysis using liquid-chromatography coupled to quadrupole time-of-flight mass spectrometry.
    Dubbelman AC; Cuyckens F; Dillen L; Gross G; Vreeken RJ; Hankemeier T
    Anal Chim Acta; 2018 Aug; 1020():62-75. PubMed ID: 29655429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in software tools for high-throughput in vitro ADME support with high-resolution MS.
    Paiva A; Shou WZ
    Bioanalysis; 2016 Aug; 8(16):1723-33. PubMed ID: 27487387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput quantitative bioanalysis by LC/MS/MS.
    Jemal M
    Biomed Chromatogr; 2000 Oct; 14(6):422-9. PubMed ID: 11002279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel LC-MS approach for the detection of metabolites in DMPK studies.
    Plumb RS; Mather J; Little D; Rainville PD; Twohig M; Harland G; Kenny DJ; Nicholson JK; Wilson ID; Kass IJ
    Bioanalysis; 2010 Oct; 2(10):1767-78. PubMed ID: 21083328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
    Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
    J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
    Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
    J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).
    Mück W
    Pharmazie; 1999 Sep; 54(9):639-44. PubMed ID: 10522267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outsource-ability of high-resolution MS-based DMPK assays.
    Rago B; Negahban A
    Bioanalysis; 2016 Aug; 8(16):1641-4. PubMed ID: 27416917
    [No Abstract]   [Full Text] [Related]  

  • 11. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS systems for quantitative bioanalysis.
    van Dongen WD; Niessen WM
    Bioanalysis; 2012 Oct; 4(19):2391-9. PubMed ID: 23088465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
    Liu ZY
    J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated sample preparation and LC-MS for high-throughput ADME quantification.
    O'Connor D
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):52-8. PubMed ID: 11865673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a five-channel multiplexed electrospray quadrupole time-of-flight hybrid mass spectrometer for metabolite identification.
    Leclercq L; Delatour C; Hoes I; Brunelle F; Labrique X; Castro-Perez J
    Rapid Commun Mass Spectrom; 2005; 19(12):1611-8. PubMed ID: 15915450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interview: challenges faced by the modern bioanalytical laboratory.
    Sangster T; Oliver M
    Bioanalysis; 2012 Oct; 4(19):2329-33. PubMed ID: 23088459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HRMS using a Q-Exactive series mass spectrometer for regulated quantitative bioanalysis: how, when, and why to implement.
    Sturm RM; Jones BR; Mulvana DE; Lowes S
    Bioanalysis; 2016 Aug; 8(16):1709-21. PubMed ID: 27460982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.